US FDA lifts partial clinical hold on Rezolute's blood sugar treatment
09/09/2024 12:38
Sept 9 (Reuters) - Rezolute Inc RZLT.O said on Monday the U.S. Food and Drug Administration has removed the partial clinical hold on its late-stage study testing its experimental treatment for low blood sugar. (Reporting by Sneha S K; Editing by Vijay Kishore) ((Sneha.SK@thomsonreuters.com;))